Chapman Timothy J, Castrucci Maria R, Padrick Ryan C, Bradley Linda M, Topham David J
Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, Aab Institute of Biomedical Sciences, University of Rochester Medical Center, NY 14642, USA.
Virology. 2005 Sep 30;340(2):296-306. doi: 10.1016/j.virol.2005.06.023.
To track epitope-specific CD4(+) T cells at a single-cell level during influenza infection, the MHC class II-restricted OVA(323-339) epitope was engineered into the neuraminidase stalk of influenza/A/WSN, creating a surrogate viral antigen. The recombinant virus, influenza A/WSN/OVA(II), replicated well, was cleared normally, and stimulated both wild-type and DO11.10 or OT-II TCR transgenic OVA-specific CD4(+) T cells. OVA-specific CD4 T cells proliferated during infection only when the OVA epitope was present. However, previously primed (but not naive) transgenic CD4(+) T cells were recruited to the infected lung both in the presence and absence of the OVA(323-339) epitope. These data show that, when primed, CD4(+) T cells may traffic to the lung in the absence of antigen, but do not proliferate. These results also document a useful tool for the study of CD4 T cells in influenza infection.
为了在流感感染期间在单细胞水平追踪表位特异性CD4(+) T细胞,将MHC II类限制性OVA(323 - 339)表位设计到甲型流感病毒/WSN的神经氨酸酶柄中,从而产生一种替代病毒抗原。重组病毒甲型流感病毒/WSN/OVA(II)复制良好,能正常清除,并刺激野生型以及DO11.10或OT-II TCR转基因OVA特异性CD4(+) T细胞。只有当OVA表位存在时,OVA特异性CD4 T细胞才会在感染期间增殖。然而,无论是否存在OVA(323 - 339)表位,先前致敏(而非未致敏)的转基因CD4(+) T细胞都会被募集到受感染的肺部。这些数据表明,致敏后的CD4(+) T细胞在没有抗原的情况下可能会迁移到肺部,但不会增殖。这些结果还证明了一种用于研究流感感染中CD4 T细胞的有用工具。